Hypersensitivity myocarditis associated with ephedra use

Journal of Toxicology - Clinical Toxicology

Volumn 37, Issue 4, 1999, Pages 485-489

  Zaacks, Stephen M ^a   Klein, Lloyd ^a   Tan, Carmela D ^a   Rodriguez, E Rene ^a   Leikin, Jerrold B ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; EPHEDRINE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DYSPNEA; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART MUSCLE BIOPSY; HUMAN; HYPERSENSITIVITY; MALE; MYOCARDITIS; RESPIRATORY DISTRESS; VASCULITIS;

ADULT; ALKALOIDS; DRUG HYPERSENSITIVITY; EPHEDRA; FOOD ADDITIVES; HUMANS; HYPERTENSION; MALE; MYOCARDITIS; PLANTS, MEDICINAL; POLYPHARMACY; SYMPATHOMIMETICS;

EPHEDRA;

EID: 0032791709     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102440     Document Type: Article

References (16)

1. Wooten MR, Khangure MS, Murphy MJ. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neurol 1983;13:337-340.
2. Loizou LA, Hamilton JG, Tsementzis SA. Intracranial hemorrhage in association with pseudoephedrine overdose. J Neurol Neurosurg Psychiatry 1982;45:471-475.
3. Glick R, Hoying J, Cerullo L, Perlman S. Phenylpropanolamine: An over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery 1987;20:969-974.
4. Kase CS, Foster TE, Reed JE, Spatz EL, Girgis GN. Intracerebral hemorrhage and phenylpropanolamine use. Neurology 1987;37:399-404.
5. LeCoz P, Woimant F, Rougemont D, et al. Angiopathies cerébrales bénigns et phenylpropanolamine. Rev Neurol 1988;144:295-300.
6. Leo PJ, Hollander JE, Shih RD, Marcus SM. Phenylpropanolamine and associated myocardial injury. Ann Emerg Med 1996;28:359-362.
7. Rosenblum I, Wohl A, Stein A. Studies in cardiac necrosis: Production of cardiac lesions with sympathomimetic amines. Toxicol Appl Pharmacol 1965;7:1-8.
8. Chappel CJ, Rong G, Balazst et al. Comparison of cardiotoxic actions of certain sympathomimetic anines. Can J Biochem Physiol 1959;37:35-42.
9. Szakacs JE, Cannon A. L-norepinephrine myocarditis. Am J Clin Pathol 1958;30:425-434.
10. Hyams JS, Leichtner AM, Breiner RG, et al. Pseudopheochromocytoma and cardiac arrest associated with phenylpropanolamine. JAMA 1985;253:1609-1610.
11. Pentel PR, Jentzen J, Sievert J. Myocardial necrosis due to intraperitoneal administration of phenylpropanolamine in rats. Fundam Appl Toxicol 1987;9:167-172.
12. Pentel P. Toxicity of over-the-counter stimulants. JAMA 1984;252:1898-1903.
13. Pentel PR, Mikell FL, Zavoral JH. Myocardial injury after phenylpropanolamine ingestion. Br Heart J 1982; 47:51-54.
14. Wynne J, Braunwald E. The cardiomyopathies and myocarditis. In: Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Braunwald E, ed., Philadelphia: WB Saunders 1997:1404-1463.
15. Personal Communication, David Katzin, M.D., Ph.D., Chairman of Medical Advisory Board, Herbalife, September 1, 1998.
16. To LB, Sangster JF, Rampling D, Cammens I. Ephedrine-induced cardiomyopathy. Med J Aust 1980;2:35-36.